Genetic alterations in TRAF3 and CYLD that regulate nuclear factor κB and interferon signaling define head and neck cancer subsets harboring human papillomavirus
- PMID: 28295216
- PMCID: PMC5419858
- DOI: 10.1002/cncr.30659
Genetic alterations in TRAF3 and CYLD that regulate nuclear factor κB and interferon signaling define head and neck cancer subsets harboring human papillomavirus
Abstract
Intriguingly, recent genomic studies of HNSCC by The Cancer Genome Atlas (TCGA) as well as other groups identified deletions or mutations in TNF-receptor associated factor (TRAF3) and Cylindromatosis (CYLD; Turban Tumor Syndrome) that were previously implicated in NF-κB and anti-viral Interferon responses. Hajek et al find genomic alterations in TRAF3/CYLD define distinct subsets of HPV+ HNSCC with associated activation of transcription factor NF-κB, episomal HPV infection of tumors, and improved survival of patients.
Conflict of interest statement
Comment on
-
TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.Cancer. 2017 May 15;123(10):1778-1790. doi: 10.1002/cncr.30570. Epub 2017 Mar 13. Cancer. 2017. PMID: 28295222 Free PMC article.
References
-
- Van Waes C. Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clinical Cancer Research. 2007;13:1076–1082. - PubMed
-
- DiDonato JA, Mercurio F, Karin M. NF-kappaB and the link between inflammation and cancer. Immunological Reviews. 2012;246:379–400. - PubMed
-
- Allen C, Saigal K, Nottingham L, et al. Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-|kappa}B subunits in head and neck cancer. Clinical Cancer Research. 2008;14:4175–4185. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
